The White House has withdrawn the nomination of Heidi Overton, a senior domestic policy adviser for President Trump, for commissioner of the FDA. CIDRAP has the news.
Senator Bill Cassidy, a Louisiana Republican who currently heads the Senate Committee on Health, Education, Labor and Pensions, wrote that he was disappointed in the decision and saw a path to confirmation for Overton. The White House’s claim was that she did not have the votes required to pass, but Cassidy countered that he believed she would have had the votes to pass the full Senate.
Cassidy also suggested that some senators wanted the White House to commit more strongly to anti-abortion policies. Now, since the Senate flipped to Democratic control in the midterms, confirming a permanent FDA commissioner will fall to a newly blue majority. Some leaders of the Make America Healthy Again (MAHA) movement were also critical of Overton.
Kyle Diamantas has been the acting FDA commissioner since May, when Marty Makary, who had served for just over a year, resigned.